Lin Elizabeth H B, Katon Wayne, Rutter Carolyn, Simon Greg E, Ludman Evette J, Von Korff Michael, Young Bessie, Oliver Malia, Ciechanowski Paul C, Kinder Leslie, Walker Edward
Center for Health Studies, Group Health Cooperative, Seattle, Wash 98101, USA.
Ann Fam Med. 2006 Jan-Feb;4(1):46-53. doi: 10.1370/afm.423.
Among patients with diabetes, major depression is associated with more diabetic complications, lower medication adherence, and poorer self-care of diabetes. We reported earlier that enhanced depression care reduces depression symptoms but not hemoglobin A1c level. This study examined effects of depression interventions on self-management among depressed diabetic patients.
A total of 329 patients in 9 primary care clinics were randomized to an evidence-based collaborative depression treatment (pharmacotherapy, problem-solving treatment, or both in combination) or usual primary care (routine medical services). Outcome measures included the Summary of Diabetes Self-Care Activities (SDSCA), reported at baseline and 3, 6, and 12 months, and medication non-adherence as assessed by automated pharmacy refill data of oral hypoglycemic agents, lipid-lowering agents, and angiotensin-converting enzyme inhibitors. We used mixed regression models adjusted for baseline differences to compare the intervention with usual care groups at follow-up assessments.
During the 12-month intervention period, enhanced depression care and outcomes were not associated with improved diabetes self-care behaviors (healthy nutrition, physical activity, or smoking cessation). Relative to the usual care group, the intervention group reported a small decrease in body mass index (mean difference = 0.70 kg/m2, 95% CI, 0.17 to 1.24 kg/m2) and a higher rate of nonadherence to oral hypoglycemic agents (mean difference = -6.3%, 95% CI, -11.91% to -0.71%). Adherence to lipid-lowering agents and to antihypertensive medicines was similar for the 2 groups.
In general, diabetes self-management did not improve among the enhanced depression treatment group during a 12-month period, except for small between-group differences of limited clinical importance. Research needs to assess whether self-care interventions tailored for specific conditions, in addition to enhanced depression care, can achieve better diabetes and depression outcomes.
在糖尿病患者中,重度抑郁症与更多的糖尿病并发症、更低的药物依从性以及更差的糖尿病自我护理相关。我们之前报告过,强化抑郁症护理可减轻抑郁症状,但对糖化血红蛋白水平无影响。本研究探讨了抑郁症干预对抑郁糖尿病患者自我管理的影响。
9家基层医疗诊所的329名患者被随机分为循证协作抑郁症治疗组(药物治疗、解决问题疗法或两者结合)或常规基层医疗组(常规医疗服务)。结局指标包括糖尿病自我护理活动总结(SDSCA),在基线、3个月、6个月和12个月时报告,以及通过口服降糖药、降脂药和血管紧张素转换酶抑制剂的自动药房配药数据评估的药物不依从情况。我们使用针对基线差异进行调整的混合回归模型,在随访评估时比较干预组与常规护理组。
在12个月的干预期内,强化抑郁症护理及结局与改善糖尿病自我护理行为(健康营养、体育活动或戒烟)无关。相对于常规护理组,干预组报告体重指数略有下降(平均差异 = 0.70 kg/m²,95% CI,0.17至1.24 kg/m²),口服降糖药的不依从率更高(平均差异 = -6.3%,95% CI,-11.91%至-0.71%)。两组降脂药和抗高血压药物的依从性相似。
总体而言,在12个月期间,强化抑郁症治疗组的糖尿病自我管理并未改善,除了具有有限临床重要性的微小组间差异。研究需要评估除强化抑郁症护理外,针对特定情况量身定制的自我护理干预措施是否能实现更好的糖尿病和抑郁症结局。